These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 32410504)
1. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study. Khan MT; Ali A; Wang Q; Irfan M; Khan A; Zeb MT; Zhang YJ; Chinnasamy S; Wei DQ J Biomol Struct Dyn; 2021 Jul; 39(10):3627-3637. PubMed ID: 32410504 [TBL] [Abstract][Full Text] [Related]
2. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape. Rampogu S; Gajula RG; Lee G; Kim MO; Lee KW Comput Biol Med; 2021 Aug; 135():104525. PubMed ID: 34252682 [TBL] [Abstract][Full Text] [Related]
3. A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition. Gaudêncio SP; Pereira F Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33322052 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study. Khan MT; Ali A; Wei X; Nadeem T; Muhammad S; Al-Sehemi AG; Wei D Braz J Biol; 2022; 84():e250667. PubMed ID: 35475989 [TBL] [Abstract][Full Text] [Related]
6. Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach. Bhowmick S; Saha A; Osman SM; Alasmary FA; Almutairi TM; Islam MA Mol Divers; 2021 Aug; 25(3):1979-1997. PubMed ID: 33844135 [TBL] [Abstract][Full Text] [Related]
7. Natural inhibitors of SARS-CoV-2 main protease: structure based pharmacophore modeling, molecular docking and molecular dynamic simulation studies. Halimi M; Bararpour P J Mol Model; 2022 Aug; 28(9):279. PubMed ID: 36031629 [TBL] [Abstract][Full Text] [Related]
8. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151 [TBL] [Abstract][Full Text] [Related]
9. Computational screening for potential drug candidates against the SARS-CoV-2 main protease. Silva Andrade B; Ghosh P; Barh D; Tiwari S; José Santana Silva R; Rodrigues de Assis Soares W; Silva Melo T; Santos Freitas A; González-Grande P; Sousa Palmeira L; Carlos Junior Alcantara L; Giovanetti M; Góes-Neto A; Ariston de Carvalho Azevedo V F1000Res; 2020; 9():. PubMed ID: 33447372 [No Abstract] [Full Text] [Related]
10. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease. Gogoi N; Chowdhury P; Goswami AK; Das A; Chetia D; Gogoi B Mol Divers; 2021 Aug; 25(3):1745-1759. PubMed ID: 33236176 [TBL] [Abstract][Full Text] [Related]
11. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease. Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750 [TBL] [Abstract][Full Text] [Related]
12. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Gupta Y; Kumar S; Zak SE; Jones KA; Upadhyay C; Sharma N; Azizi SA; Kathayat RS; Poonam ; Herbert AS; Durvasula R; Dickinson BC; Dye JM; Rathi B; Kempaiah P Bioorg Med Chem; 2021 Oct; 47():116393. PubMed ID: 34509862 [TBL] [Abstract][Full Text] [Related]
14. In Silico Evaluation of Sesquiterpenes and Benzoxazinoids Phytotoxins against M Mejías FJR; Durán AG; Chinchilla N; Varela RM; Álvarez JA; Molinillo JMG; García-Cozar F; Macías FA Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136537 [TBL] [Abstract][Full Text] [Related]
15. Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M J A; Francis D; C S S; K G A; C S; Variyar EJ J Biomol Struct Dyn; 2022 Jan; 40(1):325-336. PubMed ID: 32873185 [TBL] [Abstract][Full Text] [Related]
16. Investigating the structure-activity relationship of marine polycyclic batzelladine alkaloids as promising inhibitors for SARS-CoV-2 main protease (M Elgohary AM; Elfiky AA; Pereira F; Abd El-Aziz TM; Sobeh M; Arafa RK; El-Demerdash A Comput Biol Med; 2022 Aug; 147():105738. PubMed ID: 35777088 [TBL] [Abstract][Full Text] [Related]
17. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV. Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605 [TBL] [Abstract][Full Text] [Related]